Tierp, Sweden

Lars-Göran Axelsson

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Lars-Göran Axelsson: Innovator in Medical Research

Introduction

Lars-Göran Axelsson is a notable inventor based in Tierp, Sweden. He has made significant contributions to the field of medical research, particularly in the area of inflammation and cell migration. With a total of 4 patents to his name, Axelsson's work is paving the way for advancements in therapeutic methods.

Latest Patents

Axelsson's latest patents focus on compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells. One of his key inventions involves methods for administering isolated oligonucleotides to influence the behavior of these cells, thereby reducing their migration to sites of inflammation in human patients. This innovative approach has the potential to significantly impact treatment strategies for various inflammatory conditions.

Career Highlights

Lars-Göran Axelsson is associated with Index Pharmaceuticals AB, where he continues to develop groundbreaking solutions in the medical field. His research emphasizes the therapeutic effectiveness of oligonucleotides in managing inflammation, showcasing his commitment to improving patient outcomes.

Collaborations

Axelsson collaborates with talented professionals in his field, including Arezou Zargari and Oliver Von Stein. Their combined expertise enhances the research and development efforts at Index Pharmaceuticals AB.

Conclusion

Lars-Göran Axelsson's innovative work in the realm of medical research exemplifies the importance of scientific advancements in treating inflammation. His contributions are vital to the ongoing evolution of therapeutic methods in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…